Subtype classification of malignant lymphoma using immunohistochemical staining pattern
By
Noriaki Hashimoto
Kaho Ko
Tatsuya Yokota
Kei Kohno
Masato Nakaguro
Shigeo Nakamura
Ichiro Takeuchi
Hidekata Hontani
February 11, 2022
Clinical Scorecard: Classification of Malignant Lymphoma Subtypes Through Immunohistochemical Staining Patterns
At a Glance
Category Detail
Condition Malignant lymphoma with over 70 subtypes
Key Mechanisms Identification of lymphoma subtypes via morphological features on H&E-stained tissue slides and immunohistochemical (IHC) staining patterns
Target Population Patients with malignant lymphoma undergoing pathological diagnosis
Care Setting Pathology laboratories utilizing whole slide imaging and digital pathology analysis
Key Highlights
Subtype classification relies on initial H&E-stained slide observation followed by selection of IHC stains to confirm diagnosis. Typicality of morphological features on H&E slides is quantitatively evaluated based on the sets of IHC stains used for definitive diagnosis. Instance selection based on typicality improves generalization ability of subtype classification models using MIL-based CNNs.
Guideline-Based Recommendations
Diagnosis
Begin with microscopic examination of H&E-stained tissue slides to infer candidate lymphoma subtypes. Select IHC stains based on initial subtype candidates to confirm definitive diagnosis. Recognize that typical morphological features require fewer IHC stains, while atypical features necessitate additional stains.
Management
Use subtype identification to guide appropriate lymphoma treatment strategies.
Monitoring & Follow-up
Employ digital pathology and machine learning tools to assist in subtype classification and monitor diagnostic accuracy.
Risks
Potential overfitting of classification models if training data includes atypical instances without appropriate selection. Misclassification risk if atypical morphological features are not adequately accounted for.
Patient & Prescribing Data
Patients diagnosed with malignant lymphoma subtypes including DLBCL, AITL, and CHL
Accurate subtype classification via typicality-based instance selection supports tailored therapeutic decisions.
Clinical Best Practices
Incorporate typicality evaluation of H&E-stained slides based on IHC stain sets to select training data for machine learning models. Utilize MIL-based convolutional neural networks to focus on cancerous regions within whole slide images without manual annotations. Recognize variability in IHC stain sets both within and between lymphoma subtypes to inform diagnostic strategies.
References